Search research articles
Contact Us
Filters
Showing results (461-470 of 482) with videos related to
Page
of 49
Sort By:
Blood Advances
|
June 5, 2023
A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma
Annalisa Arcari, Lugi Rigacci, Alessandra Tucci, et al.
Leukemia
|
August 13, 2020
Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study
Carlo Visco, Alice Di Rocco, Andrea Evangelista, et al.
Leukemia
|
January 23, 2021
Correction: Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study
Carlo Visco, Alice Di Rocco, Andrea Evangelista, et al.
British Journal of Haematology
|
November 9, 2018
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death
Carlo Visco, Maria C Tisi, Andrea Evangelista, et al.
Eclinicalmedicine
|
April 18, 2024
Marginal zone lymphoma international prognostic index: a unifying prognostic index for marginal zone lymphomas requiring systemic treatment
Luca Arcaini, Côme Bommier, Juan Pablo Alderuccio, et al.
Blood Advances
|
August 23, 2021
Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders
James Peter Stewart, Jana Gazdova, Nikos Darzentas, et al.
Blood Advances
|
June 25, 2026
Renoir phase III Rituximab-Lenalidomide vs Rituximab as Maintenance Treatment in Relapsed/Refractory Follicular Lymphoma
Barbara Botto, Carola Boccomini, Andrea Evangelista, et al.
Hemasphere
|
June 8, 2026
Clonal hematopoiesis dynamics influences long-term outcomes of follicular lymphoma: Results from FIL FOLL12 trial
Nawar Maher, Riccardo Moia, Mohammad Almasri, et al.
Blood Advances
|
March 19, 2026
Quantitative MYD88 L265P and flow cytometry levels for outcome determination in IgM gammopathies: the SAL-TO study
Irene Dogliotti, Cristina Jiménez, Veronica Peri, et al.
Human Reproduction Open
|
March 17, 2025
Uterine smooth muscle tumours with uncertain malignant potential: reproductive and clinical outcomes in patients undergoing fertility-sparing management
Umberto Leone Roberti Maggiore, Francesco Fanfani, Giovanni Scambia, et al.
Page
of 49
Search research articles
Search
Showing results (461-470 of 482) with videos related to
Sort By:
Page
of 49
Blood Advances
|
June 5, 2023
A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma
Annalisa Arcari, Lugi Rigacci, Alessandra Tucci, et al.
Leukemia
|
August 13, 2020
Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study
Carlo Visco, Alice Di Rocco, Andrea Evangelista, et al.
Leukemia
|
January 23, 2021
Correction: Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study
Carlo Visco, Alice Di Rocco, Andrea Evangelista, et al.
British Journal of Haematology
|
November 9, 2018
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death
Carlo Visco, Maria C Tisi, Andrea Evangelista, et al.
Eclinicalmedicine
|
April 18, 2024
Marginal zone lymphoma international prognostic index: a unifying prognostic index for marginal zone lymphomas requiring systemic treatment
Luca Arcaini, Côme Bommier, Juan Pablo Alderuccio, et al.
Blood Advances
|
August 23, 2021
Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders
James Peter Stewart, Jana Gazdova, Nikos Darzentas, et al.
Blood Advances
|
June 25, 2026
Renoir phase III Rituximab-Lenalidomide vs Rituximab as Maintenance Treatment in Relapsed/Refractory Follicular Lymphoma
Barbara Botto, Carola Boccomini, Andrea Evangelista, et al.
Hemasphere
|
June 8, 2026
Clonal hematopoiesis dynamics influences long-term outcomes of follicular lymphoma: Results from FIL FOLL12 trial
Nawar Maher, Riccardo Moia, Mohammad Almasri, et al.
Blood Advances
|
March 19, 2026
Quantitative MYD88 L265P and flow cytometry levels for outcome determination in IgM gammopathies: the SAL-TO study
Irene Dogliotti, Cristina Jiménez, Veronica Peri, et al.
Human Reproduction Open
|
March 17, 2025
Uterine smooth muscle tumours with uncertain malignant potential: reproductive and clinical outcomes in patients undergoing fertility-sparing management
Umberto Leone Roberti Maggiore, Francesco Fanfani, Giovanni Scambia, et al.
Page
of 49